Bull market on its last legs? Not so, says Birinyi

Bull market on its last legs? Not so, says Birinyi
Given the stampede on Wall Street over the past few days, it's no surprise that clients are a little freaked out. But legendary stock picker Lazlo Birinyi isn't fazed. Despite the drama, he says 'the bull market is intact.'
AUG 08, 2011
Laszlo Birinyi, one of the first investors to recommend buying when the bull market began in 2009, said the Standard & Poor's 500 Index will continue its ascent, though possibly not to the level he had predicted. “The bull market is intact, and while our ‘target' of 1,450 in mid-2012 is admittedly a bit shaky, our more important conclusion that a rational, disciplined portfolio can attain a 10 percent plus return in 2011 is not,” Birinyi, of Westport, Connecticut-based research firm Birinyi Associates Inc., wrote in a note today. The S&P 500 has plunged in 10 of the past 11 days, wiping out almost $3 trillion in market value, as a political battle over the U.S. debt ceiling prompted Standard & Poor's to cut the country's debt rating. Birinyi said there's no fundamental reason for the slide, and equities will continue the rally that took the S&P 500 69 percent higher since March 2009. “The decline is, we submit, in large part political, not financial, which makes us somewhat more optimistic,” Birinyi wrote. “It is impossible to segregate the political from the financial but we would hope that at some point, financial trumps political, which has historically been the case.” The benchmark gauge for U.S. equities climbed 2.1 percent to 1,142.37 at 1:33 p.m. today in New York. That curbed losses since July 22 to 15 percent, data compiled by Bloomberg show. Equity strategists estimate the S&P 500 will climb to 1,389 by the end of the year, according to the average forecast in a Bloomberg survey. Unlikely to Gain Birinyi said financial companies and banks, commodity stocks and health-care companies are unlikely to outperform as the rally continues. Financial companies historically are underperformers after the first part of a bull market and dividend-paying stocks, such as pharmaceutical companies, aren't necessarily a good investment, Birinyi said. Dividend investing is “an excellent strategy for the current environment,” Oppenheimer & Co.'s New York-based chief investment strategist, Brian Belski, wrote in an Aug. 8 note. JPMorgan Chase & Co. recommend today that investors buy General Electric Co. and Johnson & Johnson for their dividend yields. Energy and financial shares and are two of the three worst performing groups in the S&P 500 since July 22, losing more than 18 percent. “Despite our stance, we are not necessarily excited about the prospects for the indices,” Birinyi said. “Our preference continues to be for individual discrete names which may have few common characteristics.” --Bloomberg News--

Latest News

Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans
Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans

Wells Fargo adds two bank-channel recruits, UBS lands a JPMorgan Chase veteran, and a multi-family office lifts Atlas past $1B

Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state
Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state

“The state comes down on you in years when you make 40% returns for clients,” said Bill Swayne, the advisor and son of Candace Swayne.

Osaic in talks with Anthropic as AI reshapes advisor workforce
Osaic in talks with Anthropic as AI reshapes advisor workforce

The Independent broker-dealer giant has had “active conversations” with the Claude maker, which is days away from its expected IPO

The retirement milestone advisors aren't tracking
The retirement milestone advisors aren't tracking

For Gen X clients entering life after work, answering the financial question isn't enough to solve the entire retirement equation.

Wealthtech firms target stock pay, pensions and heirs for advisors
Wealthtech firms target stock pay, pensions and heirs for advisors

Tools from Grantd, Income Lab and Healthspan Wealth aim to keep RIAs involved in clients’ biggest money decisions

SPONSORED Best Practices for Engaging Women Around Alternatives

Growing wealth, evolving priorities, and untapped opportunities are reshaping how women approach long-term investing.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.